Sign in
4

Changes in Ownership

TScan Therapeutics, Inc. Filed Acc 0000950170-23-068925

Options or other derivatives

  • Director acquired 17,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Woods Keith Director 2023-12-06 Grant or award · Stock Option (Right to Buy) +17,500 17,500 D
Loading xslF345X05/ownership.xml…